Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders (Q43997962)

28 November 2017

title

Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders (English)

1 reference

28 November 2017

0 references

1

1 reference

28 November 2017

A S Gibbons

2

1 reference

28 November 2017

N Tawadros

3

1 reference

28 November 2017

L Brooks

4

1 reference

28 November 2017

I P Everall

5

1 reference

28 November 2017

E Scarr

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

17 July 2012

1 reference

28 November 2017

1 reference

28 November 2017

volume

18

1 reference

28 November 2017

issue

7

1 reference

28 November 2017

page(s)

767-773

1 reference

Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: evidence from human peripheral studies and CNS studies

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Th2 cytokine response in Major Depressive Disorder patients before treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Inflammation in psychotic disorders: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Relationship of behavioural and symptomatic syndromes in schizophrenia to spatial working memory and attentional set-shifting ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Neural mechanisms of autonomic, affective, and cognitive integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Expression of TNF-alpha leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Disruptive insights in psychiatry: transforming a clinical discipline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Cell death assays for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Synaptic targeting of the postsynaptic density protein PSD-95 mediated by lipid and protein motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Human postmortem tissue: what quality markers matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Problem of diagnosis in postmortem brain studies of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Phospholipase C beta 1 expression in the dorsolateral prefrontal cortex from patients with schizophrenia at different stages of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Random-effects models for longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Pro-interleukin (IL)-1beta shares a core region of stability as compared with mature IL-1beta while maintaining a distinctly different configurational landscape: a comparative hydrogen/deuterium exchange mass spectrometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Up-regulation of microglial CD11b expression by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Stroop performance in bipolar disorder: further evidence for abnormalities in the ventral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha transgenic mice, one characterized by neurological disorders, the other phenotypically normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Immune variations in bipolar disorder: phasic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

Cytokine imbalance in the pathophysiology of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Cytokine production and treatment response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Procedures for Detecting Outlying Observations in Samples

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.95

7 January 2021

Identifiers

DOI

10.1038/MP.2012.95

1 reference

28 November 2017

1 reference